Jim Olson
@jimolson.bsky.social
Drug discovery, focused on pediatrics. Biotech entrepreneur. Leader of Invent@SC Postdoctoral Program. 30+ years of caring for kids with brain tumors. Comments are my own.
Pinned
Jim Olson
@jimolson.bsky.social
· Jan 27
Invent at Seattle Children’s Scholar Profile: Dr. Akinsola Oyelakin
YouTube video by Seattle Children's
youtu.be
Meet Akinsola Oyelakin, an Invent@SC scholar who seeks to halt schizophrenia progression. Please share broadly.
#postdoc #academicsky #biotech #jobs #science #therapeutics #biotechsky #SeattleChildren's #UniversityofWashington #FredHutch #BenaroyaResearchInstitute
youtu.be/owOiCEzNmKs
#postdoc #academicsky #biotech #jobs #science #therapeutics #biotechsky #SeattleChildren's #UniversityofWashington #FredHutch #BenaroyaResearchInstitute
youtu.be/owOiCEzNmKs
Reposted by Jim Olson
I visited this lab when at FDA — lead for pharmaceutical quality, key for investigations of contaminants in drug supply. If this move interrupts agency function, it’s a big deal.
DOGE terminates lease on FDA pharma quality lab in St. Louis that employs about 70 scientists - unclear on their fate endpts.com/doge-shutter...
DOGE terminates lease on FDA quality lab in St. Louis, and 29 other sites
DOGE says that it has terminated the leases of 30 FDA offices and buildings, including a 52,000 square-foot St. Louis-based lab that operates under the FDA's Office of Pharmaceutical Quality.
endpts.com
March 5, 2025 at 12:33 AM
I visited this lab when at FDA — lead for pharmaceutical quality, key for investigations of contaminants in drug supply. If this move interrupts agency function, it’s a big deal.
Delighted to speak at Stand up for Science! Bring your kids!
Hope to see many of my colleagues on Friday.
www.eventbrite.com/e/stand-up-f...
Science is for everyone.
For everyone to do, and for everyone to benefit from.
Weather forecast has also improved for Friday, but waterproof your posters just in case.
www.eventbrite.com/e/stand-up-f...
Science is for everyone.
For everyone to do, and for everyone to benefit from.
Weather forecast has also improved for Friday, but waterproof your posters just in case.
Stand Up for Science 2025 - Seattle, WA
Stand up for science with us on March 7th, 2025, because science is for everyone! More info at www.standupforscience2025.org
www.eventbrite.com
March 6, 2025 at 1:45 AM
Delighted to speak at Stand up for Science! Bring your kids!
Reposted by Jim Olson
It is important at this pivotal moment to @standupforscience.bsky.social. Looking forward to sharing my thoughts on why this should be a national priority at tomorrow’s rally in SF:
March 5, 2025 at 4:54 PM
It is important at this pivotal moment to @standupforscience.bsky.social. Looking forward to sharing my thoughts on why this should be a national priority at tomorrow’s rally in SF:
Can I still write "cis" and "trans" in my grant application? Due Monday...
January 31, 2025 at 4:28 AM
Can I still write "cis" and "trans" in my grant application? Due Monday...
Reposted by Jim Olson
Congratulations to the recipients of the 2025 Damon Runyon-Rachleff Innovation Award! Five exceptional scientists received initial grants, and three previous awardees were given Stage 2 support to continue their critical work. Read more: www.damonrunyon.org/news/entries...
Damon Runyon Cancer Research Foundation awards $3.2M to innovative early-career scientists
www.damonrunyon.org
January 28, 2025 at 5:06 PM
Congratulations to the recipients of the 2025 Damon Runyon-Rachleff Innovation Award! Five exceptional scientists received initial grants, and three previous awardees were given Stage 2 support to continue their critical work. Read more: www.damonrunyon.org/news/entries...
Meet Akinsola Oyelakin, an Invent@SC scholar who seeks to halt schizophrenia progression. Please share broadly.
#postdoc #academicsky #biotech #jobs #science #therapeutics #biotechsky #SeattleChildren's #UniversityofWashington #FredHutch #BenaroyaResearchInstitute
youtu.be/owOiCEzNmKs
#postdoc #academicsky #biotech #jobs #science #therapeutics #biotechsky #SeattleChildren's #UniversityofWashington #FredHutch #BenaroyaResearchInstitute
youtu.be/owOiCEzNmKs
Invent at Seattle Children’s Scholar Profile: Dr. Akinsola Oyelakin
YouTube video by Seattle Children's
youtu.be
January 27, 2025 at 6:12 PM
Meet Akinsola Oyelakin, an Invent@SC scholar who seeks to halt schizophrenia progression. Please share broadly.
#postdoc #academicsky #biotech #jobs #science #therapeutics #biotechsky #SeattleChildren's #UniversityofWashington #FredHutch #BenaroyaResearchInstitute
youtu.be/owOiCEzNmKs
#postdoc #academicsky #biotech #jobs #science #therapeutics #biotechsky #SeattleChildren's #UniversityofWashington #FredHutch #BenaroyaResearchInstitute
youtu.be/owOiCEzNmKs
Reposted by Jim Olson
The antidote for despair is action ❤️
* Dial (202) 224-3121
* Enter zip code
* Leave voicemail
* Say “My name is ___, I’m a constituent in [town]. (If clinician/scientist, say so)
“The NIH freeze harms research and patients and must be lifted immediately.”
Be brief. Staffers tally all calls. Go! ✅
* Dial (202) 224-3121
* Enter zip code
* Leave voicemail
* Say “My name is ___, I’m a constituent in [town]. (If clinician/scientist, say so)
“The NIH freeze harms research and patients and must be lifted immediately.”
Be brief. Staffers tally all calls. Go! ✅
NIH funding supports the vast majority of all biomedical research in the United States. Virtually every advance in American medicine and biological science comes from NIH. This is a blow against American science.
Call Congress, 202-224-3121.
Call Congress, 202-224-3121.
All NIH study sections canceled indefinitely. This will halt science and devastate research budgets in universities.
January 23, 2025 at 3:21 AM
The antidote for despair is action ❤️
* Dial (202) 224-3121
* Enter zip code
* Leave voicemail
* Say “My name is ___, I’m a constituent in [town]. (If clinician/scientist, say so)
“The NIH freeze harms research and patients and must be lifted immediately.”
Be brief. Staffers tally all calls. Go! ✅
* Dial (202) 224-3121
* Enter zip code
* Leave voicemail
* Say “My name is ___, I’m a constituent in [town]. (If clinician/scientist, say so)
“The NIH freeze harms research and patients and must be lifted immediately.”
Be brief. Staffers tally all calls. Go! ✅
Reposted by Jim Olson
Have questions about the 2025 #HannaGrayFellows Program?
Join us for one of our informational webinar to learn more about the application process & what it means to be part of this incredible program:
Wed, 1.23.25 | 3:30–4:30PM ET
Thu, 1.30.25 | 3:30–4:30PM ET
Register today! hhmi.news/40ymhuq
Join us for one of our informational webinar to learn more about the application process & what it means to be part of this incredible program:
Wed, 1.23.25 | 3:30–4:30PM ET
Thu, 1.30.25 | 3:30–4:30PM ET
Register today! hhmi.news/40ymhuq
January 17, 2025 at 3:15 PM
Have questions about the 2025 #HannaGrayFellows Program?
Join us for one of our informational webinar to learn more about the application process & what it means to be part of this incredible program:
Wed, 1.23.25 | 3:30–4:30PM ET
Thu, 1.30.25 | 3:30–4:30PM ET
Register today! hhmi.news/40ymhuq
Join us for one of our informational webinar to learn more about the application process & what it means to be part of this incredible program:
Wed, 1.23.25 | 3:30–4:30PM ET
Thu, 1.30.25 | 3:30–4:30PM ET
Register today! hhmi.news/40ymhuq
Reposted by Jim Olson
#FDA grants accelerated approval to HER2/HER3 bispecific ab
#zenocutuzumab for previously treated advanced #NSCLC and #pancreatic cancer and #NRG1 fusion. Thanks to patients, PIs (Ali Schram, Alex Drilon, Jordi Rodon, Eileen O'Reilly, and others) #OncSky #MedSky
www.fda.gov/drugs/resour...
#zenocutuzumab for previously treated advanced #NSCLC and #pancreatic cancer and #NRG1 fusion. Thanks to patients, PIs (Ali Schram, Alex Drilon, Jordi Rodon, Eileen O'Reilly, and others) #OncSky #MedSky
www.fda.gov/drugs/resour...
FDA grants accelerated approval to zenocutuzumab-zbco
On December 4, 2024, the FDA granted accelerated approval to zenocutuzumab-zbco for non-small cell lung cancer and pancreatic adenocarcinoma.
www.fda.gov
December 5, 2024 at 12:33 AM
#FDA grants accelerated approval to HER2/HER3 bispecific ab
#zenocutuzumab for previously treated advanced #NSCLC and #pancreatic cancer and #NRG1 fusion. Thanks to patients, PIs (Ali Schram, Alex Drilon, Jordi Rodon, Eileen O'Reilly, and others) #OncSky #MedSky
www.fda.gov/drugs/resour...
#zenocutuzumab for previously treated advanced #NSCLC and #pancreatic cancer and #NRG1 fusion. Thanks to patients, PIs (Ali Schram, Alex Drilon, Jordi Rodon, Eileen O'Reilly, and others) #OncSky #MedSky
www.fda.gov/drugs/resour...
Great team for a great cause! Thanks for investing in the education of next generation scientific leaders!
Meet the 2025 Timmerman Traverse for Damon Runyon Cancer Research Foundation team. Trekking to Everest Base Camp in April. Raising $ for bold and brave cancer researchers. Roster & Sponsors--> timmermanreport.com/2024/11/meet...
Meet the 2025 Timmerman Traverse for Damon Runyon Cancer Research Team - TimmermanReport.com
I’m excited to announce the 2025 Timmerman Traverse for Damon Runyon Cancer Research Foundation team. This group of 17 men and women are on a mission to raise more than $700,000 for the next generatio...
timmermanreport.com
November 27, 2024 at 4:07 AM
Great team for a great cause! Thanks for investing in the education of next generation scientific leaders!
Reposted by Jim Olson
ASCO annual meeting 2025 abstract submitter open - closes Jan 28th.
To support global innovation in cancer research, payment waivers offered to 1st authors from low- & lower-middle-income countries (World Bank)!
Apply for a waiver when you submit an abstract
conferences.asco.org/am/abstract-...
To support global innovation in cancer research, payment waivers offered to 1st authors from low- & lower-middle-income countries (World Bank)!
Apply for a waiver when you submit an abstract
conferences.asco.org/am/abstract-...
ASCO Meetings
conferences.asco.org
November 23, 2024 at 3:10 PM
ASCO annual meeting 2025 abstract submitter open - closes Jan 28th.
To support global innovation in cancer research, payment waivers offered to 1st authors from low- & lower-middle-income countries (World Bank)!
Apply for a waiver when you submit an abstract
conferences.asco.org/am/abstract-...
To support global innovation in cancer research, payment waivers offered to 1st authors from low- & lower-middle-income countries (World Bank)!
Apply for a waiver when you submit an abstract
conferences.asco.org/am/abstract-...
Big shout out to our valued colleagues at the #NIH, #FDA, & #CDC. Each person that I've worked with has been smart, hardworking, and committed to the health of our country. While it would be shocking if we agreed with every decision or process, these colleagues have earned and retain my trust.
November 23, 2024 at 10:11 PM
Reposted by Jim Olson
I finally compiled my recs for newbies of how to learn about the drug dev biz into a blog post: www.linkedin.com/pulse/how-le...
How to learn about biotech and pharma
Since joining Tufts University Department of Biology, I've been helping upper-level biology majors and biology MS/PhD students explore non-academic / non-medical career options. Many them have questio...
www.linkedin.com
November 21, 2024 at 3:02 AM
I finally compiled my recs for newbies of how to learn about the drug dev biz into a blog post: www.linkedin.com/pulse/how-le...
#Gradstudents new to Bluesky and interested in discovering new therapeutics - please check out Invent@SC #postdoc scholars program. Biotech training & mentors. Salary starts at $80k/year.
“The majority has spoken, and researchers are moving en masse” to Bluesky, says @shaine.bsky.social.
Couldn't help myself and had to write about science twitter, X, bluesky and "the migration"...
www.science.org/content/arti... 🧪
Couldn't help myself and had to write about science twitter, X, bluesky and "the migration"...
www.science.org/content/arti... 🧪
Like ‘old Twitter’: The scientific community finds a new home on Bluesky
After recent changes to Elon Musk’s X, a gradual migration turns into a stampede
www.science.org
November 22, 2024 at 2:29 AM
#Gradstudents new to Bluesky and interested in discovering new therapeutics - please check out Invent@SC #postdoc scholars program. Biotech training & mentors. Salary starts at $80k/year.
Reposted by Jim Olson
The pioneers in Barcelona are at it again: now with point-of-care tandem vectors CD19/BCMA. Local manufacturing drives innovation. This is a really good pre-clinical manuscript for those interested in CAR formats #ASGCT #ASH2024
www.cell.com/molecular-th...
www.cell.com/molecular-th...
ARI0003: Co-transduced CD19/BCMA Dual-targeting CAR-T Cells for the Treatment of Non-Hodgkin Lymphoma
Guedan and colleagues demonstrates the potential of BCMA as a cotarget with CD19 for
lymphoma treatment. They address challenges of imbalanced CAR expression after cotransduction
and demonstrate the s...
www.cell.com
November 21, 2024 at 1:19 PM
The pioneers in Barcelona are at it again: now with point-of-care tandem vectors CD19/BCMA. Local manufacturing drives innovation. This is a really good pre-clinical manuscript for those interested in CAR formats #ASGCT #ASH2024
www.cell.com/molecular-th...
www.cell.com/molecular-th...
Congrats on your remarkable accomplishments, Sam. Best wishes to the Day One team as they enter the next chapter. #biosky
I have some news to share.
I'll have a little more to say about it in the coming days. Those of you who know me well, know that I'm right now trying to find the right way to put things into words. More soon.
ir.dayonebio.com/news-release...
I'll have a little more to say about it in the coming days. Those of you who know me well, know that I'm right now trying to find the right way to put things into words. More soon.
ir.dayonebio.com/news-release...
Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development | Day One Biopharmaceuticals, Inc.
Dr. Blackman’s departure planned for end of 2024 Company’s search for a new Head of R&D is ongoing BRISBANE, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (...
ir.dayonebio.com
November 22, 2024 at 2:21 AM
Congrats on your remarkable accomplishments, Sam. Best wishes to the Day One team as they enter the next chapter. #biosky
Interested in discovering novel therapeutics that benefit children? Seattle Children's, UW, Fred Hutch, and Benaroya Research Institute offer postdocs starting at $80K. Please spread the word! #academicsky #blacksky
November 15, 2024 at 11:31 PM
Interested in discovering novel therapeutics that benefit children? Seattle Children's, UW, Fred Hutch, and Benaroya Research Institute offer postdocs starting at $80K. Please spread the word! #academicsky #blacksky
Encourage #postdocs interested in #biotech to read this article. Some academic centers are trying to fill the de-risking space. Hope these added costs and labor are recognized when companies spin out so that the practice is rewarded enough to be sustainable.
Hi all! I'll be cross-posting my stories, as well as those from the rest of the Biopharma Dive team, here as well. Be sure to check this one out, which has some great insights on what it takes to build and fund a biotech startup these days.
alright, we’re back on this place — which means it’s time for me to post my work here again! i hosted a #biotech panel with @benthefidler.bsky.social this week and here are some of the key takeaways: www.biopharmadive.com/news/biotech...
November 15, 2024 at 10:20 PM
Looking forward to building a strong biotech & academic community on Bluesky. 10 minutes a day...
Giving this place a try. Thanks @dshaywitz.bsky.social for the gentle nudge. Would be nice to have good-faith discussions and debates about the latest in health science. Looking for more signal, less noise.
November 14, 2024 at 5:23 PM
Looking forward to building a strong biotech & academic community on Bluesky. 10 minutes a day...
First Bluesky post: NYTimes highlights our work on scorpion venom for cancer surgical guidance. www.nytimes.com/2024/11/13/m...
Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.
www.nytimes.com
November 13, 2024 at 8:09 PM
First Bluesky post: NYTimes highlights our work on scorpion venom for cancer surgical guidance. www.nytimes.com/2024/11/13/m...